Therapeutic targeting of noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and
long noncoding RNAs (lncRNAs), represents an attractive approach for the treatment of …

SARS-CoV-2 is a novel coronavirus that infects cells through the angiotensin-converting
enzyme 2 receptor, aided by proteases that prime the spike protein of the virus to enhance …

Cumulative data link cytokine storms with coronavirus disease 2019 (COVID-19) severity.
The precise identification of immune cell subsets in bronchoalveolar lavage (BAL) and their …

Background Patients infected with the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), responsible for the coronavirus disease 2019 (COVID-19), exhibit a wide …

The coronavirus disease 2019 (COVID-19) was a global endemic that continues to cause a
large number of severe illnesses and fatalities. There is increasing evidence that non-coding …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has been looming globally for
three years, yet the diagnostic and treatment methods for COVID-19 are still undergoing …

Introduction: One of the hallmarks of COVID-19 is overwhelming inflammation, which plays a
very important role in the pathogenesis of COVID-19. Thus, identification of inflammatory …

The interferon‐inducible protein with tetrapeptide repeats 3 (IFIT3) is one of the most
important members in both the IFIT family and interferon‐stimulated genes family. IFIT3 has …

The long non‐coding RNAs (lncRNAs) play a critical regulatory role in the host response to
the viral infection. However, little is understood about the transcriptome architecture …

Coronavirus disease 2019 (COVID-19), which has high incidence rates with rapid rate of
transmission, is a pandemic that spread across the world, resulting in more than 3,000,000 …